A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D046508:Culture Techniques; D003561:Cytarabine / Q000494:pharmacology*; D003596:Cytosine; D004267:DNA Viruses / Q000187:drug effects*; D004770:Enterovirus / Q000187:drug effects; D006566:Herpesviridae Infections / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008722:Methods; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009705:Nucleosides / Q000494:pharmacology*; D009975:Orthomyxoviridae / Q000187:drug effects; D012328:RNA Viruses / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D018139:Simplexvirus / Q000187:drug effects; D014616:Vaccinia virus / Q000187:drug effects
D000970:Antineoplastic Agents; D009705:Nucleosides; D003561:Cytarabine; D003596:Cytosine